What is glucagon like peptide? Learn how GLP-1 works in the body, how it affects blood sugar and appetite, and what GLP-1 drugs and side effects to expect.
Glucagon-like peptide is a hormone your gut and brain produce that helps control blood sugar, digestion, and appetite. The best-known version, GLP-1, is released after you eat and signals your pancreas to release insulin. Drugmakers copied that hormone to build a class of prescription medicines used for type 2 diabetes and weight loss.
What Is Glucagon-Like Peptide? The Basics
Glucagon-like peptides belong to the incretin family, a group of gut hormones released when food enters your digestive tract. They are made by L cells in the small intestine and colon, and smaller amounts are produced in the brainstem.
The name comes from the structure of the molecule. Glucagon-like peptide-1 shares part of its amino acid sequence with glucagon, the hormone that raises blood sugar, even though the two hormones usually push in opposite directions.
Your body makes GLP-1 mainly as GLP-1(7-36) and GLP-1(7-37), and an enzyme called DPP-4 breaks it down within a couple of minutes. That very short lifespan is why scientists had to modify the natural molecule before it could work as a medicine.
GLP-1 is not the only incretin. Glucose-dependent insulinotropic polypeptide, or GIP, works alongside it, and newer drugs are designed to hit both receptors at once.
What Does Glucagon-Like Peptide 1 Do in the Body?
If you ask what does glucagon-like peptide 1 do, the short answer is that it helps your body manage a meal from the first bite to the next one.
- Triggers insulin: GLP-1 tells the pancreas to release insulin when blood sugar rises, and it does so in a glucose-dependent way.
- Calms glucagon: It reduces glucagon release, which limits how much extra glucose the liver pushes into the bloodstream.
- Slows stomach emptying: Food leaves the stomach more gradually, so glucose enters the blood at a steadier pace.
- Reduces appetite: GLP-1 acts on appetite centers in the hypothalamus and brainstem, which increases feelings of fullness.
- Supports beta cells: Lab and animal studies suggest GLP-1 helps pancreatic beta cells survive and keep working.
Together, these effects keep post-meal blood sugar steadier and often reduce how much a person eats. People with type 2 diabetes frequently have a weaker GLP-1 response, which is one reason the hormone became a drug target.
GLP-1 vs. GLP-2: Same Family, Different Jobs
Glucagon-like peptides come in more than one form, and they are easy to mix up. GLP-1 handles glucose and appetite, while GLP-2 focuses on the lining of the gut.
| Feature | GLP-1 | GLP-2 |
|---|---|---|
| Main role | Blood sugar control, appetite, digestion speed | Intestinal growth and repair |
| Insulin effect | Increases insulin release | Little to no direct effect |
| Appetite effect | Reduces hunger | Not a primary function |
| Prescription use | Type 2 diabetes, weight management | Short bowel syndrome (teduglutide) |
Both peptides are broken down by DPP-4, but only GLP-1 became a household name through diabetes and weight loss drugs.
Glucagon-Like Peptide-1 Receptor Agonist Drugs
A glucagon-like peptide-1 receptor agonist is a lab-made molecule that binds the GLP-1 receptor and switches on the same signals as the natural hormone. The key difference is staying power: these drugs resist DPP-4 breakdown, so a single dose can keep the receptor active for days.
| Drug | Common brand names | FDA-approved uses |
|---|---|---|
| Semaglutide | Ozempic, Wegovy, Rybelsus | Type 2 diabetes, chronic weight management |
| Liraglutide | Victoza, Saxenda | Type 2 diabetes, chronic weight management |
| Dulaglutide | Trulicity | Type 2 diabetes |
| Exenatide | Byetta, Bydureon | Type 2 diabetes |
| Tirzepatide | Mounjaro, Zepbound | Type 2 diabetes, chronic weight management (dual GIP/GLP-1) |
Every one of these is a prescription medicine in the United States, and none of them is a cure for diabetes or obesity. Names in this space get confusing quickly: tirzepatide is a dual GIP/GLP-1 drug, and people who search what is triz peptide are usually chasing a similar-sounding term rather than a real GLP-1 medication.
Glucagon-Like Peptide-1 Weight Loss and Metabolic Effects
The buzz around glucagon-like peptide-1 weight loss results is the main reason these drugs dominate headlines. In large trials, semaglutide and tirzepatide produced average weight losses in the range of about 15% to 21% of body weight over roughly a year and a half, alongside diet and exercise counseling.
The weight loss comes from two places. GLP-1 agonists quiet appetite signals in the brain, and they slow stomach emptying so meals feel more filling for longer.
A few practical points matter here:
- Results vary widely between individuals, and some people lose far less than the trial averages.
- Weight often returns if the medication is stopped without other changes.
- Muscle mass can drop along with fat, so protein intake and strength training matter.
- These drugs are meant to support, not replace, nutrition and activity habits.
Glucagon-Like Peptide-1 Side Effects and Safety
Most of what you read about glucagon-like peptide-1 side effects refers to the prescription drugs rather than the hormone your body makes on its own. The natural hormone is released and cleared within minutes, so it does not cause drug-style side effects at normal levels.
Common drug side effects include:
- Nausea, vomiting, and diarrhea
- Constipation and abdominal pain
- Appetite suppression that feels too strong
- Injection site reactions or headache
These usually ease after the first few weeks or after a dose adjustment. More serious risks, though rare, include pancreatitis, gallbladder disease, gastroparesis, and dehydration-related kidney problems. Some GLP-1 drugs carry a boxed warning about thyroid C-cell tumors seen in rodents, so they are not recommended for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
GLP-1 products sold as supplements are not FDA-approved, and compounded versions have drawn regulatory warnings. Anyone considering a GLP-1 medication should review risks, dosing, and monitoring with a healthcare professional.
The bottom line is that glucagon-like peptide is a natural hormone with real metabolic power, and the drugs built from it are effective but not risk-free. GLP-1 is not FDA-approved as a supplement ingredient for human use, and no online peptide product replaces medical care.
Frequently Asked Questions
Is glucagon-like peptide 1 a hormone or a drug?
GLP-1 is naturally a hormone your gut and brain produce after you eat. The drug versions, called GLP-1 receptor agonists, are synthetic molecules designed to act like the hormone while lasting much longer in the body. So GLP-1 itself is a hormone, while Ozempic, Wegovy, and similar products are prescription drugs that mimic it.
What foods boost glucagon-like peptide 1 naturally?
Protein-rich meals, high-fiber foods, and fermented foods have been linked to higher GLP-1 release in small studies. Eating slowly and limiting large amounts of refined sugar also supports a steadier incretin response. No food or supplement comes close to the effect of a prescription GLP-1 drug.
Are GLP-1 drugs safe for weight loss?
Prescription GLP-1 drugs are FDA-approved for chronic weight management in people who meet specific BMI criteria. They cause real side effects and carry rare but serious risks, including pancreatitis and gallbladder disease, so medical supervision matters. They are not appropriate for everyone, including people with a personal or family history of medullary thyroid cancer.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.